L. Giurgea

1.3k total citations
8 papers, 892 citations indexed

About

L. Giurgea is a scholar working on Reproductive Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, L. Giurgea has authored 8 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Reproductive Medicine, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in L. Giurgea's work include Ovarian cancer diagnosis and treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). L. Giurgea is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). L. Giurgea collaborates with scholars based in Belgium, Netherlands and Italy. L. Giurgea's co-authors include C. Coens, S. Pecorelli, Saverio Tateo, Ignace Vergote, J. B. Vermorken, C. Madroñal, Massimo Piergiuseppe Franchi, Gerardo Zanetta, C. Mangioni and J. Baptist Trimbos and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

L. Giurgea

8 papers receiving 872 citations

Peers

Countries citing papers authored by L. Giurgea

Since Specialization

Citations

This map shows the geographic impact of L. Giurgea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Giurgea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Giurgea more than expected).

Fields of papers citing papers by L. Giurgea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Giurgea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Giurgea. The network helps show where L. Giurgea may publish in the future.

Co-authorship network of co-authors of L. Giurgea

This figure shows the co-authorship network connecting the top 25 collaborators of L. Giurgea. A scholar is included among the top collaborators of L. Giurgea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Giurgea. L. Giurgea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study 2017 ·Annals of Oncology ·(unknown), Catherine Fortpied, George Koutsodontis, Margaritis Avgeris, Christos Κroupis, Nikolaοs Goutas, Jessica Menis, (unknown), L. Giurgea, Éva Remenár, M. Degardin, Ioannis S. Pateras, Johannes A. Langendijk, Carla M.L. van Herpen, Ahmad Awada, Josep Ramón Germà-Lluch, H. Kienzer, Lisa Licitra, J. B. Vermorken	11
2	Long-term update of the 24954 EORTC phase III trial on larynx preservation 2016 ·European Journal of Cancer ·(unknown), Catherine Fortpied, Jessica Menis, Jean Louis Lefèbvre, Luigi Barzan, D. De Raucourt, Lionnel Geoffrois, L. Giurgea, P. Hupperets, C. René Leemans, Lisa Licitra, Frédéric Rolland, Margot Tesselaar, Jan B. Vermorken, Vincent Grégoire	26
3	BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study 2010 ·Journal of Clinical Oncology ·Marinus H. J. van Oers, Evelyn Tönnissen, M. van Glabbeke, L. Giurgea, Joop H. Jansen, Richard Klasa, Robert Marcus, Max Wolf, Eva Kimby, Andrej Vranovský, Harald Holte, Anton Hagenbeek, Bert A. van der Reijden	34
4	Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study 2010 ·Journal of Clinical Oncology ·Marinus H. J. van Oers, M. van Glabbeke, L. Giurgea, Richard Klasa, Robert Marcus, Max Wolf, Eva Kimby, M. van ‘t Veer, Andrej Vranovský, Harald Holte, Anton Hagenbeek	225
5	Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy 2003 ·International Journal of Gynecological Cancer ·Martine Piccart, Anne Floquet, Giovanna Scarfone, Pax H.B. Willemse, Janusz Emerich, I. Vergote, L. Giurgea, C. Coens, Ahmad Awada, Jan B. Vermorken	83
6	Intraperitoneal (IP) Cisplatin (P) Versus No Further Treatment: 8 Year-Results of an Eortcgcg Randomized Phase III Study in Ovarian Cancer (O.C.) Patients (PTS) With a Pathologically Complete Remission (PCR) After P-Based Induction Chemotherapy (CT) and Cytoreductive Surgery 2003 ·International Journal of Gynecological Cancer ·Martine Piccart, Anne Floquet, Giovanna Scarfone, P.H.B. Willemse, A Kobierska, B Chevallier, Ahmad Awada, Ignace Vergote, L. Giurgea, Corneel Coens, (unknown)	5
7	Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial 2003 ·JNCI Journal of the National Cancer Institute ·J. Baptist Trimbos, Ignace Vergote, Giorgio Bolis, J. B. Vermorken, C. Mangioni, C. Madroñal, Massimo Piergiuseppe Franchi, Saverio Tateo, Gerardo Zanetta, (unknown), L. Giurgea, P.J. Timmers, C. Coens, S. Pecorelli	489
8	First Results of a Randomised Trial Comparing Radiotherapy Versus- Observation Post Operatively in Patients With Uterine Sarcomas. An EORTC-GCG Study 2003 ·International Journal of Gynecological Cancer ·Nicholas S. Reed, Costantino Mangioni, Henric Malmström, Giovanna Scarfone, A. Poveda, Saverio Tateo, S. Pecorelli, L. Giurgea, Corneel Coens, Ignace Vergote, Ivana Teodorović	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact